Montenegro Medical Device Regulations 2026: CINMED and National Requirements
Manufacturers seeking to market medical devices in Montenegro in 2026 must comply with Montenegro’s national medical device framework, which is closely aligned with EU MDR 2017/745 but operates as a standalone national system. Montenegro is not a member of the European Union or the European Economic Area, meaning EU-specific obligations such as mandatory EUDAMED registration do not apply directly. Instead, manufacturers must navigate Montenegro’s own registration process overseen by the national regulatory authority.
Who Regulates Medical Devices in Montenegro?
Medical devices in Montenegro are regulated by the Institute for Medicines and Medical Devices of Montenegro, known as CINMED (Institut za lijekove i medicinska sredstva Crne Gore). The Ministry of Health works alongside CINMED and is responsible for adopting implementing regulations, supervising conformity assessment bodies, and resolving classification disputes. CINMED’s responsibilities include maintaining the national register of medical devices and manufacturers, authorizing importation of devices, approving clinical investigations, monitoring vigilance, and coordinating with international regulatory authorities.
Legal Framework
The primary governing legislation is the Law on Medical Devices (Official Gazette of Montenegro, No. 024/19), which establishes requirements for safety, performance, classification, and conformity assessment across the device lifecycle. This law is supplemented by several rulebooks, including the Rulebook on basic requirements for medical devices (Official Gazette No. 008/24), the Rulebook on labeling and content of instructions for use (Official Gazette No. 047/23), and the Rulebook on recognition of foreign documents, CE marking, and registration of medical devices (Official Gazette No. 85/22, 126/22).
Device Classification
Montenegro uses a risk-based classification system aligned with EU MDR, dividing devices into four classes: Class I (low risk), Class IIa (low to medium risk), Class IIb (medium to high risk), and Class III (high risk). Devices are further categorized as general medical devices, in vitro diagnostics, or active implantable medical devices. Classification disputes are resolved by the Ministry of Health. Combination products containing both a device and a drug are classified based on their primary intended purpose.
CE Marking and Conformity Assessment
CE marking under EU MDR is not legally required to place a device on the Montenegrin market in the same way it is within the EU, but it plays an important practical role. A CE certificate under MDR or IVDR can be used to demonstrate compliance with international standards and support the local conformity assessment process with CINMED. Montenegro does not have a formal regulatory reliance pathway, but CE documentation is accepted and expected as part of the national registration dossier. Class I devices may follow simplified assessment procedures, while higher-risk devices require involvement of a conformity assessment body. Documentation supporting conformity must be retained for at least five years.
Transition Period for 2026
Montenegro’s national transition timeline mirrors the EU MDR transition framework. Devices may continue to be placed on the Montenegrin market through December 2027 and 2028 if they remain in compliance with the previously applicable directives, provided there have been no significant modifications to the design or intended purpose, the device does not pose an unacceptable risk to health or safety, and the manufacturer has established a Quality Management System in accordance with MDR requirements. Manufacturers with devices in transition should confirm their specific deadline with CINMED.
National Registration
Unlike EU member states, Montenegro requires separate national device registration with CINMED. Devices must be listed on Montenegro’s national register before being placed on the market. Applications for registration may be submitted by the manufacturer established in Montenegro or, for manufacturers not established in Montenegro, by their authorized representative established in Montenegro. This is a Montenegro-specific local representative requirement, distinct from the EU Authorized Representative role, and the representative must have a registered seat or residence in Montenegro.
Language and Labeling Requirements
All device labeling and Instructions for Use must be in Montenegrin. The Rulebook on labeling and content of instructions for use (Official Gazette No. 047/23) sets out the specific requirements for what must appear on labels and in IFUs for devices marketed in Montenegro. Failure to comply with these requirements can prevent registration or trigger corrective action from CINMED.
Clinical Investigations
Clinical investigations conducted in Montenegro require approval from CINMED. Applications must comply with the documentation and safety reporting standards set out in the Law on Medical Devices. Montenegro’s clinical research infrastructure is developing, and manufacturers should engage with CINMED early in the planning process.
Market Overview
Montenegro’s medical device market is largely dependent on imports, with significant contributions from Germany, Italy, Austria, Switzerland, and the United States. Key areas of demand include cardiovascular diagnostic tools, non-invasive surgical devices, anesthesia and intensive care equipment, diagnostic imaging such as CTs and MRIs, ultrasound equipment, and laboratory and testing tools. The market is small but growing, and manufacturers with CE-marked devices are well positioned to leverage their existing documentation for the national registration process.
Key Takeaways for 2026
To successfully commercialize a medical device in Montenegro, manufacturers should understand that Montenegro operates a standalone national registration system outside of the EU and EEA frameworks, engage with CINMED for national device registration ahead of commercialization, appoint a Montenegro-based local authorized representative if not established in Montenegro, prepare CE marking documentation under EU MDR as this supports the national conformity assessment process, ensure all labeling and Instructions for Use are in Montenegrin, confirm applicable transition deadlines if the device is currently certified under the previous directives, and implement post-market surveillance and vigilance processes aligned with Montenegro’s national requirements. Proactive engagement with CINMED and centralized compliance planning are critical for efficient market access.
Ready to Modernize Your Regulatory Operations?
RegDesk is an AI-powered Regulatory Information Management platform built for medical device and IVD companies managing compliance across global markets. From regulatory intelligence and submission management to post-market surveillance and lifecycle tracking, RegDesk centralizes everything your team needs to stay ahead of requirements, reduce manual work, and accelerate market access.
Teams using RegDesk have cut submission preparation time by over 80% and expanded into new markets faster with less resources.
See how RegDesk can work for your team. Book a demo today.
